[1]
2020. Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?. Brazilian Journal of Pharmaceutical Sciences. 56, (Dec. 2020), e18309 . DOI:https://doi.org/10.1590/s2175-97902020000218309.